Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low incidence of postoperative infectious complications following laparoscopic distal gastrectomy for locally advanced gastric cancer in older adult patients above 75 years: Propensity score-matched comparison with open distal gastrectomy.
Morimoto Y, Sakuramoto S, Sugita H, Nishibeppu K, Ebara G, Fujita S, Fujihata S, Oya S, Miyawaki Y, Sato H, Yamashita K. Morimoto Y, et al. Asian J Endosc Surg. 2024 Oct;17(4):e13371. doi: 10.1111/ases.13371. Asian J Endosc Surg. 2024. PMID: 39183369
Remnant gastritis in gastric cancer patients causes loss of muscle mass 6 months after gastrectomy: a retrospective cohort study of Helicobacter pylori infection.
Fujihata S, Sakuramoto S, Morimoto Y, Matsui K, Nishibeppu K, Ebara G, Fujita S, Oya S, Sugita H, Lee S, Miyawaki Y, Sato H, Takiguchi S, Yamashita K. Fujihata S, et al. Among authors: morimoto y. Surg Today. 2024 Feb;54(2):152-161. doi: 10.1007/s00595-023-02712-x. Epub 2023 Jun 23. Surg Today. 2024. PMID: 37351638
Impact of loss of skeletal muscle mass within 6-12 months after gastrectomy and S1 adjuvant chemotherapy on the survival prognosis of elderly patients with gastric cancer.
Fujihata S, Sakuramoto S, Morimoto Y, Matsui K, Nishibeppu K, Ebara G, Fujita S, Oya S, Sugita H, Lee S, Miyawaki Y, Sato H, Takiguchi S, Yamashita K. Fujihata S, et al. Among authors: morimoto y. Surg Today. 2022 Oct;52(10):1472-1483. doi: 10.1007/s00595-022-02489-5. Epub 2022 Apr 8. Surg Today. 2022. PMID: 35394206
Identifying the Trends of Urinary microRNAs within Extracellular Vesicles for Esophageal Cancer.
Hisaoka K, Matsuda S, Minoura K, Yamaguchi H, Ichikawa Y, Mizunuma M, Kobayashi R, Morimoto Y, Takeuchi M, Fukuda K, Nakamura R, Hori S, Yamazaki T, Sambe T, Kawakubo H, Kitagawa Y. Hisaoka K, et al. Among authors: morimoto y. Cancers (Basel). 2024 Apr 27;16(9):1698. doi: 10.3390/cancers16091698. Cancers (Basel). 2024. PMID: 38730650 Free PMC article.
ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?
Morimoto Y, Matsuda S, Kawakubo H, Nakamura K, Kobayashi R, Hisaoka K, Okui J, Takeuchi M, Aimono E, Fukuda K, Nakamura R, Saya H, Nishihara H, Kitagawa Y. Morimoto Y, et al. Ann Surg Oncol. 2023 Jun;30(6):3757-3758. doi: 10.1245/s10434-023-13255-3. Epub 2023 Feb 17. Ann Surg Oncol. 2023. PMID: 36807023 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 37016011
Short-term outcomes of robot-assisted minimally invasive esophagectomy with extended lymphadenectomy for esophageal cancer compared with video-assisted minimally invasive esophagectomy: A single-center retrospective study.
Morimoto Y, Kawakubo H, Ishikawa A, Matsuda S, Hijikata N, Ando M, Mayanagi S, Irino T, Nakamura R, Wada N, Tsuji T, Kitagawa Y. Morimoto Y, et al. Asian J Endosc Surg. 2022 Apr;15(2):270-278. doi: 10.1111/ases.12992. Epub 2021 Oct 12. Asian J Endosc Surg. 2022. PMID: 34637190
2,413 results